688089 Cabio Biotech(Wuhan)
- 18.09
- -0.19-1.04%
Cabio Biotech(Wuhan) News
Jiabiyou Biotechnology (Wuhan) Co., Ltd. announcement on the progress of planning major asset restructuring
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) that the transaction complies with section 11.2 of the “Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules”, section 20 of the “Measures for Continued Supervision of Companies Listed on the Science and Technology Innovation Board (Trial)”, and section 8 of the “Shanghai Stock Exchange Listed Company Major Asset Reorganization Review Rules”
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the confidentiality measures and confidentiality system adopted in this transaction
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the completeness and compliance of legal procedures and the effectiveness of submitting legal documents in this transaction
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the fluctuation in the company\'s stock price before the transaction information was released
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. that the transaction complies with the provisions of section 4 of the “Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructurings”
The board of directors explained that the entities involved in this transaction did not have section 12 of the “Supervisory Guidelines for Listed Companies No. 7 - Supervision of Abnormal Stock Transactions Related to Major Asset Restructurings of Listed Companies” or Article 30 of the “Shanghai Stock Exchange Listed Companies Self-Regulatory Guidelines No. 6 - Major Asset Restructurings”
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. that the transaction complies with the provisions of Articles 11 and 43 of the “Administrative Measures on Major Asset Restructuring of Listed Companies”
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on how this transaction is expected to constitute a related transaction
Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. that the transaction is expected to constitute a major asset restructuring but not a restructuring listing
Summary report of Cathay Pacific Junan Securities Co., Ltd. on the ongoing supervision and sponsorship of Jiabiyou Biotechnology (Wuhan) Co., Ltd.'s initial public offering of shares and listing on the Science and Technology Innovation Board
Jiabiyou: 2021 Annual Equity Distribution Implementation Notice for Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Jiabiyou: Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the 2021 profit distribution plan
Jiabiyou: Announcement by Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the acquisition of minority shareholder shares and related transactions of the holding subsidiary Zhongke Optics Valley Green Biotechnology Co., Ltd.
Jiabiyou: Announcement on the acquisition of 11% of the shares and related transactions of the holding subsidiary Zhongke Optics Valley Green Biotechnology Co., Ltd.
No Data
